Summ_uxy A point mutation in the mRNA of NADP(H): quinone oxidoreductase 1 (NQOI, DT-diaphorase) is believed to be responsible for reduced enzyme activity in the adenocarcinoma BE cell line. The 
DT-diaphorase is a two-electron-reducing flavoenzyme which catalyses the oxidation of NADH or NADPH (Ernster, 1987) . It belongs to the family of phase II detoxification enzymes. which includes glutathione S-transferase and glutathione peroxidase along with other transferases and reductases (Nebert. 1994) . This enzyme family is responsible for diverting potentially reactive electrophiles from damaging interactions with the nucleophilic groups of DNA and ultimately functions to protect tissue against carcinogenic and mutagenic compounds (Talalay and Benson, 1982) . Twoelectron reduction bypasses the formation of the semiquinone, which in the presence of oxygen can be efficiently back-oxidised, leading to the production of active oxygen species (Lind et al.. 1982; Thor et al., 1982; Fisher et al., 1992 Fisher et al., . 1993 . Once quinone-containing compounds form the semiquinone or hydroquinone a rearrangement may occur. producing an active alkylating species (Tomasz et al., 1988a.b) . Two NAD(P)H:quinone oxidoreductase isozymes were first identified in human liver. NQO1 and NQO2 (Jaiswal et al.. 1988 (Jaiswal et al.. , 1990 . NQO, is expressed in all tissues while NQO2 is only expressed in heart, lung, liver, brain and skeletal muscle . NQOI is an inducible homodimenrc enzyme in the active state. NQOI is believed to mediate most cellular quinone reduction since quinone-containing compounds are good substrates for purified human NQO, Siegel et al., 1992; Ross et al., 1993) . NQO2 also appears to be an inducible enzyme which is 54% similar to NQOI at the cDNA level (Jaiswal et al., 1990; .
The function of NQO.
has not yet been determined, although it is known that NQO2 is less effective at reducing certain quinone-containing compounds than NQOI (Jaiswal et al., 1990; . The physiological role of each form still remains uncertain (Belinsky and Jaiswal, 1993 Jaiswal, 1990; Belinsky and Jaiswal, 1993) . NQOI is known to be induced by several procarcinogens, and a perturbation in the expression of this enzyme might occur during carcinogenesis. Increased levels of NQO, gene expression have been observed in liver, lung and colon tumours, as well as in premalignant growths. indicating that this enzyme may have a role to play either in the carcinogenic process or in cellular defence mechanisms during tumour initiation (Cresteil and Jaiswal, 1991; Riley and Workman, 1992) . It is possible that a deficiency in NQO, may decrease the ability of the cell to detoxify carcinogens, thereby affecting cellular metabolic pathways and increasing the carcinogenic burden, and perhaps predisposing the affected individual to malignant disease.
Studies by Marshall et al. (1991) demonstrated a relationship between reduced DT-diaphorase activity and enhanced resistance of some cultured human fibroblast cell strains to mitomycin C (MMC), a quinone-contaiing, bioreductive DNA-alkylating chemotherapeutic agent (Lin et al., 1976; Sartorelli, 1988) . These DT-diaphorase-deficient cell strains were derived from members of a cancer-prone family, some of whom had developed malignancies (Fraumeni et al., 1.968) . Further studies by Marshall et al. (1991) and Traver et al. (1992) revealed that NQO, protein could not be detected by Western analysis in cell strains/lines which have a very low level of DT-diaphorase activity using a polyclonal antibody against rat DT-diaphorase, even though mRNA was expressed and detected by Northern blot analysis or quantitative PCR. Traver's group, using two human adenocarcinoma cell lines, HT-29 and BE, with high and low DT-diaphorase activities respectively, found a missense mutation in the mRNA of the BE cell line at nucleotide 609, which is a predicted proline to serine change at this residue. They concluded that this missense mutation may alter the secondary structure of the enzyme and thus decrease enzyme activity without affecting mRNA synthesis (Traver et al., 1992) .
The present work has extended the earlier studies of Marshall et al. (1991) and examined nine cultured human noncancerous fibroblast cell strains with varying levels of DTdiaphorase activity, five of which were derived from a single cancer-prone family. Studying human fibroblast cell strains Base aleation and DT-diaphorase actvity BL Kuehl et a) 556 of cancer-prone families may allow-genetic and biochemical changes to be detected which predispose individuals to cancer (Paterson et al.. 1986 ). The cell strains were assessed for expression of both NQO1 and NQO2 and the possible presence of a genetic alteration w hich might decrease the enzymatic activity of NQOI. and perhaps be a link to the increased susceptibility to cancer noted in this familv. The presence of an alteration in those cell strains with lowenzyme activitv would provide further evidence for the importance of the fidelity of the gene in maintaining enzy-matic activity. The results reveal that all cell strains examined express both NQOI and NQO2 mRNA. Furthermore. the base substitution at nucleotide 609 is present in approximately 50%0 of the normal population. While this base substitution is present in all of the cell strains from members of the cancer-prone family. it does not appear to have a direct effect on DT-diaphorase activity. Dignam (1978) with modifications as noted previously (Kuehl et al.. 1993 (Jaiswal et al., 1990; . Enzyme activity is therefore presented as DT-diaphorase activity. The P450R activity levels only differed over a range of 3-fold (1-3nmolmin-'mg-' protein, data not shown).
To determine if the present cell strainshlines expressed both NQO1 and NQO2 mRNAs. and the level of expression of the transcripts. quantitative reverse transcnption RT-PCR was performed to obtain predefined product sizes. Figure 2 shows a representative sequencing gel of nucleotides 600-615 from each cell type (wild-type C. heterozygous C T, homozygous T). This nucleotide substitution, which is predicted to change a proline to a senrne residue, was found even after multiple samples (2-4) were sequenced indicating that they were not incorporated PCR errors. The NQO2 cDNA from both the 3437T and the GM38 cell strains were sequenced and matched the NQO2 coding sequence (Jaiswal et al.. 1990) .
The presence of the substituted T at position 609 creates a Hinfi restriction site (G ANTC). Figure 3 demonstrates the results of the digestion for three of the human fibroblast cell strains (GM38, 3437T and 3701T). The figure shows that in the amplified product no digestion occurs in the absence of the T (GM38, 211 nucleotide fragment), while partial digestion occurs in the presence of both the C and T (3437T, 211 and 165 nucleotide fragments) and complete digestion occurs in the presence of the T only (3701T, 165 nucleotide fragment). The 45 nucleotide fragment could not be detected due to poor resolution of the gel. This restriction site was exploited to determine if this base substitution at 609 was a polymorphism present in the population or a mutation carried in this cancer-prone family. Restriction digestion of the 211 nucleotide fragment of NQO, exon 6 (Jaiswal, 1991) from 44 normal individuals with HinJI revealed that approximately 40% (18 44) of this population express both the C and T and 9% (4 44) express only the T at this position. When the cell strainshlines were examined for NQO, and NQO2 gene expression. it was found that all expressed NQO, and NQO, mRNA, and that there was no relationship between the expression of the messages and enzyme activity. This differs from the work reported by Traver et al. (1992) . which does conclude that a correlation exists between NQO, mRNA and DT-diaphorase activity in carcinoma cell lines. The lack of correlation in cell strains may reflect a more natural system which undergoes ageing-related changes. The BE cells appear to express only trace amounts of the NQO2 product but express a large amount of a larger 345 nucleotide product (Figure 1 and Table III (Jaiswal et al., 1988) at base 98 is incorrect and the G is the wild-type nucleotide. A greater number of individuals will need to be examined to verify this observation.
When the cDNA from the cell strains/lines were sequenced for genetic alterations in the NQO1 gene, it was found that four of the cell strains from the related members of the cancer prone family (3437T, 3702T, 3703T, 3704T) as well as the BE cell line contained both C and T nucleotides at position 609 of the NQO1 locus (Table III) . The 3701T cell strain appears to be homozygous for the T at nucleotide 609. In the previous report by Traver et al. (1992) the BE cell line was also reported to only express a T at nucleotide 609, in contrast to the present report, in which the BE cell line is heterozygous at nucleotide 609. One possible explanation for this discrepancy is that the BE cells previously reported have either gained a second alteration at this nucleotide or lost their wild-type allele, although the more likely explanation is the different PCR amplification and sequencing techniques employed in the present work and the previous work. Traver et al. (1992) amplified and sequenced single-stranded as opposed to double-stranded DNA. This technique may have selectively amplified the T-containing mRNA over the Ccontaining mRNA, and hence the C would not be observed.
When exon 6 was examined in the genomic DNA of 44 normal individuals it was found that approximately 40% expressed. both the C and the T while 9% expressed only the T nucleotide. Previously, it has been reported that 4-10% of the population lack DT-diaphorase activity (Edwards et al., 1980; Eickelmann et al., 1994b) and that approximately 11% of the population have an intermediate level (Edwards et al., 1980) . Several groups have speculated that the T substitution at nucleotide 609 is responsible for reduced or undetectable DT-diaphorase activity in human tissue samples (Rovold et al., 1993; Eickelmann et al., 1994a,b) . Eickelmann et al. (1994a) also demonstrated a lack of measurable DTdiaphorase activity in three patient kidney carcinoma samples and in a bladder carcinoma cell line (RT 112MMC), all of which appear to only express the T at nucleotide position 609 as determined by sequencing analysis and restriction digestion with HinfI. Regardless, the present work suggests that the function of the substituted nucleotide remains unclear since a large percentage of the population examined appear to be heterozygous at this nucleotide and, as seen in Table   III , C/T heterozygotes have widely differing DT-diaphorase activity. Using the Wilcoxon rank-sum test, the five wild-type C cell strains also demonstrated a significant difference in DT-diaphorase activity from the five C/T cell strains at the 0.05 level.
Two models are proposed for the role of the substituted T nucleotide at position 609. The first model is that the presence of the T is a polymorphism present in the population which has no functional role and no effect on DTdiaphorase activity. The second model is that the T is a missense mutation which plays a role in altering DTdiaphorase activity. Post-transcriptional regulation of DTdiaphorase activity may occur, such as decreased expression of the C-containing allele, destabilisation of the mRNA or the formation of an altered protein. Future work will require a close examination of both these models to determine how DT-diaphorase activity is regulated and the impact of this regulation. 
